First human test: new Drug's safety check begins
Knowledge-focused
Ongoing
This is the first study in humans to test the safety of a new drug called SPY003-207. It involves 59 healthy volunteers who receive a single dose to see how their bodies react and process the drug. The main goal is to check for side effects and understand how the drug moves throu…
Phase: PHASE1 • Sponsor: Spyre Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC